Post-earnings recap
Reported
Wed, Jan 30, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp reported a positive surprise in EPS, but the stock fell by 5.76% following the earnings announcement. Investors may be concerned about the lack of revenue details and forward guidance, which could indicate uncertainty about future performance. The stock reaction suggests that while the EPS beat is a positive sign, the overall market sentiment remains cautious.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.50 | N/A | +5.04% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a cautious optimism about future performance despite current market challenges. They emphasized their commitment to improving operational efficiency.
Management highlighted ongoing efforts to improve operational efficiency.
They acknowledged challenges in the market but expressed confidence in long-term strategies.